Korea Investment CORP Increases Stock Position in Axon Enterprise, Inc. (NASDAQ:AXON)

Korea Investment CORP boosted its position in Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 115.0% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 48,801 shares of the biotechnology company's stock after buying an additional 26,101 shares during the quarter. Korea Investment CORP owned approximately 0.06% of Axon Enterprise worth $29,003,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors have also bought and sold shares of AXON. Vanguard Group Inc. boosted its holdings in Axon Enterprise by 3.4% in the 4th quarter. Vanguard Group Inc. now owns 8,446,437 shares of the biotechnology company's stock worth $5,019,886,000 after buying an additional 275,959 shares during the period. Geode Capital Management LLC lifted its position in shares of Axon Enterprise by 2.0% during the third quarter. Geode Capital Management LLC now owns 1,782,828 shares of the biotechnology company's stock worth $710,103,000 after acquiring an additional 35,320 shares in the last quarter. GQG Partners LLC purchased a new position in shares of Axon Enterprise in the fourth quarter valued at $478,349,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its holdings in Axon Enterprise by 1.6% during the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 561,263 shares of the biotechnology company's stock worth $224,281,000 after purchasing an additional 9,090 shares in the last quarter. Finally, Groupama Asset Managment bought a new position in Axon Enterprise in the 3rd quarter worth about $200,000. 79.08% of the stock is owned by hedge funds and other institutional investors.

Remove Ads

Axon Enterprise Trading Up 2.0 %

NASDAQ:AXON traded up $10.55 during mid-day trading on Tuesday, reaching $536.50. 287,478 shares of the company's stock traded hands, compared to its average volume of 809,854. The company has a 50 day moving average price of $588.26 and a 200-day moving average price of $551.61. The firm has a market capitalization of $41.11 billion, a price-to-earnings ratio of 138.63, a PEG ratio of 5.17 and a beta of 1.12. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63. Axon Enterprise, Inc. has a 12-month low of $273.52 and a 12-month high of $715.99.

Wall Street Analyst Weigh In

A number of research firms have recently commented on AXON. Robert W. Baird raised their price objective on shares of Axon Enterprise from $600.00 to $800.00 and gave the company an "outperform" rating in a research report on Friday, December 6th. The Goldman Sachs Group boosted their price target on shares of Axon Enterprise from $500.00 to $700.00 and gave the company a "buy" rating in a research report on Monday, January 27th. JMP Securities reiterated an "outperform" rating on shares of Axon Enterprise in a research report on Tuesday, February 4th. Northcoast Research lowered Axon Enterprise from a "buy" rating to a "neutral" rating in a research note on Wednesday, February 19th. Finally, Morgan Stanley raised shares of Axon Enterprise from an "equal weight" rating to an "overweight" rating and raised their target price for the company from $500.00 to $700.00 in a research note on Tuesday, December 3rd. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and eleven have issued a buy rating to the company. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average target price of $604.67.

Insider Activity

In related news, Director Caitlin Elizabeth Kalinowski sold 450 shares of the stock in a transaction dated Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total value of $271,831.50. Following the completion of the transaction, the director now directly owns 6,929 shares of the company's stock, valued at $4,185,601.03. This represents a 6.10 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director Jeri Williams sold 307 shares of the company's stock in a transaction that occurred on Monday, March 17th. The stock was sold at an average price of $552.72, for a total value of $169,685.04. Following the transaction, the director now owns 1,627 shares in the company, valued at $899,275.44. This trade represents a 15.87 % decrease in their position. The disclosure for this sale can be found here. Insiders own 6.10% of the company's stock.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.